Spero Therapeutics, Inc. Other Restructuring Costs
Spero Therapeutics, Inc. (SPRO) reported Other Restructuring Costs of $3.08 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2024-03-13
- Spero Therapeutics, Inc. other restructuring costs for the quarter ending 2022-12-31 was $568.00K.
- Spero Therapeutics, Inc. other restructuring costs for the quarter ending 2022-09-30 was -$47.00K.
- Spero Therapeutics, Inc. other restructuring costs for the quarter ending 2022-06-30 was $2.56M.
- Spero Therapeutics, Inc. other restructuring costs for fiscal 2022 was $3.08M.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 9 month | Other Restructuring Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $568.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $521.00K derived: sum of 2 quarters · filed 2024-03-13 | $3.08M derived: sum of 3 quarters · filed 2024-03-13 | $3.08M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$47.00K 10-Q · filed 2022-11-14 | $2.51M derived: sum of 2 quarters · filed 2022-11-14 | $2.51M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.56M 10-Q · filed 2022-08-10 | $2.56M 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |